Suezer Y - Search Results

1

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: suezer y. J Infect Dis. 2009 Feb 1;199(3):405-13. doi: 10.1086/595984. J Infect Dis. 2009. PMID: 19061423

2

Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.

Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G, Schnierle BS, Kuiken T, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: suezer y. Vaccine. 2009 Oct 23;27(45):6296-9. doi: 10.1016/j.vaccine.2009.03.020. Vaccine. 2009. PMID: 19840663

3

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

Kreijtz JH, Suezer Y, van Amerongen G, de Mutsert G, Schnierle BS, Wood JM, Kuiken T, Fouchier RA, Lower J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: suezer y. J Infect Dis. 2007 Jun 1;195(11):1598-606. doi: 10.1086/517614. Epub 2007 Apr 17. J Infect Dis. 2007. PMID: 17471429

4

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Kreijtz JH, Suezer Y, de Mutsert G, van Amerongen G, Schwantes A, van den Brand JM, Fouchier RA, Löwer J, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: suezer y. PLoS One. 2009 Nov 12;4(11):e7790. doi: 10.1371/journal.pone.0007790. PLoS One. 2009. PMID: 19915662 Free PMC article.

5

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.

Ludwig H, Suezer Y, Waibler Z, Kalinke U, Schnierle BS, Sutter G. Ludwig H, et al. Among authors: suezer y. J Gen Virol. 2006 May;87(Pt 5):1145-1155. doi: 10.1099/vir.0.81623-0. J Gen Virol. 2006. PMID: 16603515

6

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara.

Staib C, Suezer Y, Kisling S, Kalinke U, Sutter G. Staib C, et al. Among authors: suezer y. J Gen Virol. 2006 Oct;87(Pt 10):2917-2921. doi: 10.1099/vir.0.82068-0. J Gen Virol. 2006. PMID: 16963750

7

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.

Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G. Paran N, et al. Among authors: suezer y. J Infect Dis. 2009 Jan 1;199(1):39-48. doi: 10.1086/595565. J Infect Dis. 2009. PMID: 19012492

8

Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.

Antonis AF, van der Most RG, Suezer Y, Stockhofe-Zurwieden N, Daus F, Sutter G, Schrijver RS. Antonis AF, et al. Among authors: suezer y. Vaccine. 2007 Jun 15;25(25):4818-27. doi: 10.1016/j.vaccine.2007.04.002. Epub 2007 Apr 20. Vaccine. 2007. PMID: 17499893

9

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.

Lehmann MH, Kastenmuller W, Kandemir JD, Brandt F, Suezer Y, Sutter G. Lehmann MH, et al. Among authors: suezer y. J Virol. 2009 Mar;83(6):2540-52. doi: 10.1128/JVI.01884-08. Epub 2009 Jan 7. J Virol. 2009. PMID: 19129447 Free PMC article.

10

Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.

Olszewska W, Suezer Y, Sutter G, Openshaw PJ. Olszewska W, et al. Among authors: suezer y. Vaccine. 2004 Nov 25;23(2):215-21. doi: 10.1016/j.vaccine.2004.05.015. Vaccine. 2004. PMID: 15531040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters